DDReg Pharma Insights - Check latest news and articles.

Home >

Insights

Worldwide COVID-19 Vaccine Development – A Regulatory Perspective.

October 28, 2020 Featured

The race against time to find a vaccine for the new, deadly coronavirus is well underway. Currently, over 170 candidate vaccines are being followed by the World Health Organization in an attempt to find a viable vaccine in a short span of time. While the Governments and researchers across the world are sprinting to develop …

Worldwide COVID-19 Vaccine Development – A Regulatory Perspective. Read More »

All
Article

Controlled Correspondence with FDA – An Update

March 26, 2021 Article

The US Food and Drug Administration (FDA) has recently finalized its guidance to generic drug manufacturers on how to seek drug development information through the controlled correspondence (CC) …

Generic Drug User Fee Amendments

October 28, 2020 Article

The US generic drug industry has grown into a major component of health care, with generic drugs accounting for the vast majority of retail drug prescriptions dispensed. On …

Impact of Brexit on the Pharmaceutical Industry

October 28, 2020 Article

The pharmaceutical industry is one of the most important industries that will be directly impacted by Brexit. When the United Kingdom’s referendum was held in June 2016, the …

Interested to know more?

Download Brochure

Get in touch

We can help you with our consulting expertise in pharmaceutical industry.

Contact Us

DDReg is a global pharmaceutical consulting firm that deals with regulatory services for leading pharmaceutical companies. We are trusted partner of leading pharmaceutical companies to manage their regulatory affairs portfolio.